Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Poplin
AddedApr 14, 2024
UpdatedJul 6, 2026
Poplin

Poplin

Acquired

Poplin was a pre-pregnancy wellness company offering reproductive health testing for couples.

Overview
Compare
Fundraising

Poplin was a pre-pregnancy wellness company that helped couples prepare for conception through comprehensive reproductive health testing. Founded by Alexandria DeVito, the New York-based startup positioned itself as the first dedicated pre-pregnancy wellness brand. Its service centered on at-home fertility diagnostics paired with personalized nutrition and lifestyle guidance.

Poplin ceased operating as a distinct brand, and its offering continued under 9 Months Is Not Enough, the pre-pregnancy wellness venture led by the same founder. Its former website now redirects there, confirming the brand no longer operates independently.

Poplin - Similar Companies

Poplin logo

Poplin

Poplin logo

Poplin

poplin.co

Needed logo

Needed

thisisneeded.com

Robyn logo

Robyn

wearerobyn.co

She's Well logo

She's Well

sheswell.co

Poppy Seed Health logo

Poppy Seed Health

Perelel logo

Perelel

perelelhealth.com

babyMed logo

babyMed

Claire logo

Claire

Lilia logo

Lilia

hellolilia.com

Ovia Health logo

Ovia Health

oviahealth.com

Nubundle logo

Nubundle

Poprageous logo

Poprageous

Every Mother logo

Every Mother

every-mother.com

Conceive logo

Conceive

weconceive.com

Poplin - Quick Facts

Who are Poplin's competitors?

Companies similar to Poplin include Poplin, Poplin, Needed and Robyn.

When was Poplin's last funding round?

Poplin's most recent funding round was for $20k (USD) in January 2023.

How much has Poplin raised to-date?

As of Jan 1, 2023, Poplin has raised a total of $20k (USD).

Poplin - Classification

Industry
  • Professional Service Companies
Technology
  • HealthTech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Consumers
Main Product
  • Fertility
  • Pregnancy
Tags
  • SaaS